1-(Cyclopropylcarbonyl)piperazine

We are 1-(Cyclopropylcarbonyl)piperazine CAS:59878-57-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 1-(Cyclopropylcarbonyl)piperazine
CAS.NO: 59878-57-8
Synonyms:
Cyclopropyl(1-piperazinyl)methanone
1-(cyclopropanecarbonyl)piperazine 97
Methanone, cyclopropyl-1-piperazinyl-
cyclopropyl(piperazin-1-yl)methanone

Molecular Formula:C8H14N2O
Molecular Weight: 154.21000

Physical and Chemical Properties:
Density: 1.15 g/cm3
Boiling point: 305.5ºC at 760 mmHg
Melting point:/
Flash point: 138.5±25.9 °C
Refractive index: 1.535

Specification:
Appearance:white powder
Purity:≥99%
Moisture Content: <0.5%
Impurity: <0.1%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Olaparib  CAS:763113-22-0

1-(Cyclopropylcarbonyl)piperazine


Related News: According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter.2'-Deoxycytidine-5'-monophosphate disodium salt “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.1,4-fenilendiisotiocianato CAS:4044-65-9 “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.3-Bromo-5-fluoropicolinonitrile CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

Related Products
Product Name
3-Fluoro-4-nitrophenol View Details
5-Bromo-2-pyridinecarbonitrile View Details
Tris(2-chloroethyl) Phosphite View Details
2-Aminoisonicotinic acid manufacturer (3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone manufacturer 2,9-dibutyldecanedioic acid manufacturer 1,5-Dihydroxynaphthalene manufacturer 1-BROMO-2-FLUORO-4-IODOBENZENE manufacturer